Home > Financial Ratios > ADVANCED ENZYME TECHNOLOGIES

ADVANCED ENZYME TECHNOLOGIES
Core EBITDA Growth

    Back to All Ratios
ADVANCED ENZYME TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

ADVANCED ENZYME TECHNOLOGIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -5.6832.44-12.46-13.4315.51

What is the latest Core EBITDA Growth ratio of ADVANCED ENZYME TECHNOLOGIES ?

The latest Core EBITDA Growth ratio of ADVANCED ENZYME TECHNOLOGIES is -5.68 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-5.68
Mar202432.44
Mar2023-12.46
Mar2022-13.43
Mar202115.51

How is Core EBITDA Growth of ADVANCED ENZYME TECHNOLOGIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -5.68
Negative
Mar2024 32.44
Positive
Mar2023 -12.46
Negative
Mar2022 -13.43
Negative
Mar2021 15.51 -

Other Financial Ratios of ADVANCED ENZYME TECHNOLOGIES


Compare Core EBITDA Growth ratio of peers of ADVANCED ENZYME TECHNOLOGIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES ₹3,272.0 Cr 7.1% -1.9% 2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,050.0 Cr 1.3% -4.5% -0% Stock Analytics
DIVIS LABORATORIES ₹158,157.0 Cr 1.7% -5.9% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,531.0 Cr 2.6% -5% 25.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,190.0 Cr -0.4% -7% 3.6% Stock Analytics
CIPLA ₹98,892.8 Cr 2.6% -7.4% -16.3% Stock Analytics


ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES

7.1%

-1.9%

2.8%

SENSEX

4.8%

-4.2%

0.8%


You may also like the below Video Courses